Inhibrx, Inc. (INBX) Tops Q1 EPS by 421c

Inhibrx, Inc. (NASDAQ: INBX) reported Q1 EPS of $2.80, $4.21 better than the analyst estimate of ($1.41).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Okta, Inc (OKTA) PT Raised to $162 at Guggenheim
• Daqo New Energy (DQ) Misses Q2 EPS by 67c